Alaunos Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Alaunos Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Alaunos Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Alaunos Therapeutics Inc. is TCRT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Alaunos Therapeutics Inc. has its primary listing on NASDAQ (Small cap). You can trade Alaunos Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Alaunos Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Alaunos Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Alaunos Therapeutics Inc..